Dr. Basil Schaheen, MD

Dr. Schaheen practices at Northeast Georgia Medical Center Gainesville in Gainesville, Georgia, part of Northeast Georgia Health System.

Dr. Schaheen's NPI, 1568728590, was assigned on April 4, 2012. Dr. Schaheen graduated from Jefferson Medical College of Thomas Jefferson University in 2012. Dr. Schaheen holds Georgia license 88929.

Dr. Schaheen's primary practice is Northeast Georgia Medical Center Gainesville, at 743 Spring Street, Gainesville, GA 30501 in Hall County. The practice phone is (770) 535-3553.

Dr. Schaheen's primary practice is Northeast Georgia Medical Center Gainesville in Gainesville, Georgia, part of Northeast Georgia Health System. The medical group on file is Northeast Georgia Physicians Group Inpatient Neurology. Dmand AI also links Dr. Schaheen to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Schaheen practices, 2 sites in all. Vendor and product names are available with a free account.

Plastic and reconstructive surgery is Dr. Schaheen's primary specialty in the NPI Registry, under taxonomy code 2086S0122X. Dr. Schaheen is licensed in Georgia.

CMS data shows 297 Medicare services from Dr. Schaheen across 4 procedure codes in 2024, for 189 Medicare patients. Medicare paid $29,143 for them.

CMS counts 189 Medicare patients who saw Dr. Schaheen in 2024. The largest group is 65 to 74, with 76 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 8% are also on Medicaid. Their average risk score is 1.75, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Schaheen's median patient age at 71, with 57% women.

In 2024, Dr. Schaheen wrote 497 Medicare Part D claims for 155 patients. 92% of them were for generic drugs. CMS names the drug for 442 of them, across 11 drugs with 11 or more claims each, at $2,166 in total drug cost. In 2023, CMS named 344 claims across 9 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Schaheen for performance year 2024, reported as part of a group. Dr. Schaheen accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 54 procedures of melanoma (skin cancer) excision by Dr. Schaheen, more than 87% of the clinicians it reports for that procedure.

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 8 papers to Dr. Schaheen, published from 2014 to 2020. 2016 was the busiest year, with 2. The most frequent topics are Angiotensin II, Aortic Aneurysm, Abdominal and Mice, Inbred C57BL. Dr. Schaheen has published most often in Arterioscler Thromb Vasc Biol. Dr. Schaheen's most frequent co-authors are Gilbert R. Upchurch, MD, Gorav Ailawadi, MD and Emily A. Downs, MD.

CMS Open Payments shows 128 general payments to Dr. Schaheen from 24 drug and device companies from 2021 to 2025. Food and beverage make up the largest share, 91% of the total. Abbvie Inc. paid the most, $852.

Dr. Schaheen graduated from Jefferson Medical College of Thomas Jefferson University in 2012.